ICD 10 CM C79.6 | Description & Clinical Information

ICD 10 C79.6 describes the presence of secondary malignant neoplasm of the ovary, which occurs when cancer cells from a primary cancer site spread to the ovary through the bloodstream or lymphatic channels, and is associated with risk factors such as late menopause, obesity, history of radiation therapy to the pelvis, use of infertility drugs, genetic predisposition, and long-term use of tamoxifen, a drug commonly used to treat breast cancer.

Official Description Of C79.6

The ICD 10 CM book defines ICD 10 code C79.6 as:

When To Use C79.6

The diagnosis describes by the ICD 10 code C79.6 refers to the presence of secondary malignant neoplasm of the ovary. This condition may present with a range of symptoms, including pelvic and abdominal pain, constipation, lethargy, weight loss, nausea, vomiting, indigestion, a feeling of fullness in the pelvis, leg swelling, as well as irregular, unusually heavy vaginal bleeding or postmenopausal bleeding.

To diagnose this condition, a patient’s medical history needs to be considered, along with an examination of their gynecological area, including a pap smear. Additionally, imaging tests like X-rays, CT scans, MRI, and PET, may be conducted to diagnose and stage the malignancy.

However, a thorough examination may also require the need for cystoscopy, proctoscopy, and an ovarian biopsy. Thanks to modern technology, ultrasounds may also provide further insights into the extent and location of the neoplasm.

Regrettably, secondary cancers, such as the one indicated by the C79.6 code, are notoriously challenging to manage. The primary aim of treatment is typically to control symptoms and prevent further metastasis, all while improving the quality of life for the patient.

Based on the severity of the condition, treatment protocols can vary widely, with chemotherapy frequently used in tandem with radiation therapy and surgery. Depending on the location, size, and extent of the malignancy, procedures may include oophorectomy, salpingooophorectomy, and simple or radical hysterectomy.

It is worth noting that as the medical community expands its knowledge about cancer treatment and technology advances, treatment protocols may change. However, the diagnosis of secondary malignant neoplasm of the ovary remains incredibly serious with the potential for a significant negative impact on a patient’s quality of life. Thus, proactive measures, such as regular gynecological examinations and open communication with physicians, are necessary.